Additional Data on Lumos OraGrowtH Trials Presented

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristics......

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE

– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG......

HII Hosts Chief of Naval Operations Adm. Michael Gilday at

HII Hosts Chief of Naval Operations Adm. Michael Gilday at

NEWPORT NEWS, Va., March 03, 2023 (GLOBE NEWSWIRE) -- HII (NYSE: HII) hosted Chief of Naval Operations Adm. Michael Gilday for a visit to the company’s......

Praxis Precision Medicines to Present at Upcoming Investor

Praxis Precision Medicines to Present at Upcoming Investor

BOSTON, March 03, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating......

Teladoc Health to Participate in Upcoming Investor

Teladoc Health to Participate in Upcoming Investor

PURCHASE, NY, March 03, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that......

TaskUs to Participate in the Morgan Stanley Technology,

TaskUs to Participate in the Morgan Stanley Technology,

NEW BRAUNFELS, Texas, March 03, 2023 (GLOBE NEWSWIRE) -- TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and......

Daseke Announces Chief Operating Officer Transition

Daseke Announces Chief Operating Officer Transition

Specialized Segment leader and transportation industry veteran, Scott Hoppe, to become EVP and COO effective June 1, 2023......

Cidara Therapeutics Announces Pricing of Public Offerings

Cidara Therapeutics Announces Pricing of Public Offerings

SAN DIEGO, March 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics......

TG Therapeutics Announces Data Presentations from the

TG Therapeutics Announces Data Presentations from the

NEW YORK, March 03, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data......

The Shyft Group to Present at the Raymond James 44th Annual

The Shyft Group to Present at the Raymond James 44th Annual

NOVI, Mich., March 03, 2023 (GLOBE NEWSWIRE) -- The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North American leader in specialty......

  • 1
  • ...
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • ...
  • 39
  • menu
    menu